INTERVIEW: Carmat stays on the beat with potential 2016 artificial heart CE mark

Carmat has taken another step towards approval of its biocompatible artificial heart after developing a portable console that has allowed one patient implanted with the system to return home.

Carmat has taken another step towards approval of its biocompatible artificial heart after developing a portable console that has allowed one patient implanted with the system to return home.

The patient, the second to receive the device, was implanted with the bioprosthetic heart in August. The first patient to be treated passed away in March

More from Archive

More from Medtech Insight